大肠炎中失调的骨髓分化是由炎症性骨质细胞以TNFα依赖的方式诱导的
Maria-Bernadette Madel1, Lidia Ibáñez1, Thomas Ciucci2
1Université Côte d'Azur, CNRS, LP2M, Nice, France.
Mucosal immunology
|September 27, 2024
概括
骨质细胞,参与骨破坏的细胞,通过影响血细胞发育,促进炎症性肠病 (IBD) 中的肠炎症. 抑制骨质细胞可降低结肠炎的严重程度,为IBD揭示了一个新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 骨生物学 骨生物学 骨生物学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD) 导致严重的肠道炎症和骨质损失.
- 在IBD中,骨质细胞活性增加,导致骨破坏.
- 骨质结晶体可能在慢性炎症中发挥作用,而不仅仅是骨质再吸收.
研究的目的:
- 为了研究骨质细胞在结肠炎的发病过程中的作用.
- 为了确定骨质细胞活性是否影响髓状细胞积累和肠道炎症.
- 探索向骨质细胞治疗IBD的潜力.
主要方法:
- 利用大肠炎和骨质细胞分化的小鼠模型.
- 服用骨质细胞抑制剂和RANKL来诱导/减少骨质细胞活性.
- 在结肠病小鼠的骨质细胞上进行了RNAseq分析.
- 研究了TNF-α抑制对骨质细胞诱导的骨髓状质曲的作用.
- 在克罗恩病患者中,骨质细胞活性与骨髓细胞比例相关.
主要成果:
- 骨质细胞抑制显著降低了结肠炎的严重程度.
- RANKL诱导的骨质细胞分化恶化了疾病.
- 骨质细胞在结肠炎期间促进了肠道中髓状细胞的积累.
- 骨质细胞诱导了造血原体的增殖和骨髓的歪曲.
- 抑制TNF-α缓解了骨质细胞驱动的骨髓层曲.
- 在克罗恩病患者中,骨质细胞活性与髓状细胞比例呈正相关性.
结论:
- 骨质细胞直接导致大肠炎的肠道炎症.
- 骨质细胞通过对血液形成的早期影响影响大肠炎的发病因子,增加骨髓形成.
- 向骨质细胞活动代表了IBD的新治疗策略.
更多相关视频
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
16.5K
07:51Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
5.9K
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
Inflammatory Bowel Disease II: Crohn's Disease
194
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
194
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
